1.
Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patien...
by Lahner, Edith
Clinical and translational gastroenterology, 2017-01-19, Vol.8 (1), p.e215-e215

2.
Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease
by Kriegel, Christina
Clinical and translational gastroenterology, 2011-03-24, Vol.2 (3), p.e2-e2

3.
Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
by Montano-Loza, Aldo J
Clinical and translational gastroenterology, 2015-07-16, Vol.6 (7), p.e102-e102

4.
Predictors for Pancreatic Cancer Diagnosis Following New-Onset Diabetes Mellitus
by Munigala, Satish
Clinical and translational gastroenterology, 2015-10-22, Vol.6 (10), p.e118-e118

5.
Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location
by Mima, Kosuke
Clinical and translational gastroenterology, 2016-11-03, Vol.7 (11), p.e200

6.
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
by Bournet, Barbara
Clinical and translational gastroenterology, 2016-03-24, Vol.7 (3), p.e157-e157

7.
Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome
by Schwartz, Lauren K
Clinical and translational gastroenterology, 2016-02-04, Vol.7 (2), p.e142-e142

8.
Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
by Tsuda, Ayumi
Clinical and translational gastroenterology, 2015-06-11, Vol.6 (6), p.e89-e89

9.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects
by Sakurai, Yuuichi
Clinical and translational gastroenterology, 2015-06-25, Vol.6 (6), p.e94-e94

10.
Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets
by Halmos, Emma P
Clinical and translational gastroenterology, 2016-04-14, Vol.7 (4), p.e164-e164

11.
Changes in Hepatic Venous Pressure Gradient Induced by Physical Exercise in Cirrhosis: Results of a Pilot Randomized Open Clinical Trial
by Macías-Rodríguez, Ricardo U
Clinical and translational gastroenterology, 2016-07-14, Vol.7 (7), p.e180-e180

12.
Expression Profiles of miRNA Subsets Distinguish Human Colorectal Carcinoma and Normal Colonic Mucosa
by Pellatt, Daniel F
Clinical and translational gastroenterology, 2016-03-10, Vol.7 (3), p.e152-e152

13.
Improvement in Esophageal Distensibility in Response to Medical and Diet Therapy in Eosinophilic Esophagitis
by Carlson, Dustin A
Clinical and translational gastroenterology, 2017-10-05, Vol.8 (10), p.e119-e119

14.
A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia
by Symonds, Erin L
Clinical and translational gastroenterology, 2016-01-14, Vol.7 (1), p.e137-e137

15.
Diminishing Effectiveness of Long-Term Maintenance Topical Steroid Therapy in PPI Non-Responsive Eosinophilic Esophagitis
by Eluri, Swathi
Clinical and translational gastroenterology, 2017-06-15, Vol.8 (6), p.e97-e97

16.
Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation
by Gelfond, Daniel
Clinical and translational gastroenterology, 2017-03-16, Vol.8 (3), p.e81-e81

17.
Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study
by Bang, Casper N
American journal of hypertension, 2017-09-01, Vol.30 (9), p.914-922

18.
Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome
by Acosta, Andrés
Clinical and translational gastroenterology, 2016-05-26, Vol.7 (5), p.e173-e173

19.
Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study
by Gray, Ronan T
Clinical and translational gastroenterology, 2017-04-27, Vol.8 (4), p.e91-e91

20.
Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
by Goossens, Nicolas
Clinical and translational gastroenterology, 2017-06-22, Vol.8 (6), p.e101-e101
